Triamcinolone and Atrioventricular block - a phase IV clinical study of FDA data

Summary:

Atrioventricular block is found among people who take Triamcinolone, especially for people who are female, 60+ old.

The phase IV clinical study analyzes which people take Triamcinolone and have Atrioventricular block. It is created by eHealthMe based on reports of 18,117 people who have side effects when taking Triamcinolone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Mar, 28, 2023

18,117 people reported to have side effects when taking Triamcinolone.
Among them, 8 people (0.04%) have Atrioventricular block.


What is Triamcinolone?

Triamcinolone has active ingredients of triamcinolone. eHealthMe is studying from 18,194 Triamcinolone users for its effectiveness, alternative drugs and more.

What is Atrioventricular block?

Atrioventricular block (heart block) is found to be associated with 1,563 drugs and 785 conditions by eHealthMe.

Number of Triamcinolone and Atrioventricular block reports submitted per year:

Could Triamcinolone cause Atrioventricular block?

Gender of people who have Atrioventricular block when taking Triamcinolone *:

  • female: 87.5 %
  • male: 12.5 %

Age of people who have Atrioventricular block when taking Triamcinolone *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 33.33 %
  • 50-59: 0.0 %
  • 60+: 66.67 %

Common drugs people take besides Triamcinolone *:

  1. Lantus: 6 people, 75.00%
  2. Novolog: 5 people, 62.50%
  3. Nasacort: 5 people, 62.50%
  4. Fish Oil: 5 people, 62.50%
  5. Fluoxetine: 5 people, 62.50%
  6. Cosentyx: 5 people, 62.50%
  7. Trulicity: 5 people, 62.50%
  8. Rivaroxaban: 5 people, 62.50%
  9. Metformin: 5 people, 62.50%
  10. Claritin: 4 people, 50.00%

Common side effects people have besides Atrioventricular block *:

  1. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 75.00%
  2. Heart Palpitations (feelings or sensations that your heart is pounding or racing): 4 people, 50.00%
  3. Staphylococcal Infection (an infection with staphylococcus bacteria): 3 people, 37.50%
  4. Pneumonia: 3 people, 37.50%
  5. Pacemaker Generated Arrhythmia: 3 people, 37.50%
  6. Urinary Tract Infection: 3 people, 37.50%
  7. Pain: 2 people, 25.00%
  8. Breathing Difficulty: 2 people, 25.00%
  9. Heart Rate Increased: 2 people, 25.00%
  10. Joint Pain: 2 people, 25.00%

Common conditions people have *:

  1. Psoriasis (immune-mediated disease that affects the skin): 5 people, 62.50%
  2. Hypersensitivity: 4 people, 50.00%
  3. High Blood Cholesterol: 4 people, 50.00%
  4. Diabetes: 4 people, 50.00%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 25.00%
  6. Multiple Myeloma (cancer of the plasma cells): 1 person, 12.50%
  7. Iron Deficiency: 1 person, 12.50%
  8. Calcium Deficiency (lack of calcium): 1 person, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Triamcinolone and have Atrioventricular block?

Check whether Atrioventricular block is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Atrioventricular block and when was it recovered:

Expand to all the drugs that have ingredients of triamcinolone:

Alternative drugs to, pros and cons of Triamcinolone:

Common Triamcinolone side effects:

Browse all side effects of Triamcinolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Atrioventricular block treatments and more:

COVID vaccines that are related to Atrioventricular block:

Common drugs associated with Atrioventricular block:

All the drugs that are associated with Atrioventricular block:

Common conditions associated with Atrioventricular block:

All the conditions that are associated with Atrioventricular block:

How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone (the active ingredients of Triamcinolone) and Triamcinolone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: